One of the mechanisms underlying dyslipidemia in CKD is the decreased expression of ABCA1, which leads to reduced cholesterol efflux and lipid accumulation in endothelial cells, exacerbating the risk of cardiovascular diseases. This evidence concerns the gene ABCA1 and chronic kidney disease.